Newsletter | September 20, 2021

09.20.21 -- Controlling Your Process From Idea To Injection

Viral Vector Scale-Up: How Can We Bridge The Technology Gaps?

Unlocking the full potential of viral vector-based therapies requires an understanding of existing challenges in viral vector production and which technologies are now available in upstream and downstream processing to help address them.

Strategies To Address The Viral Vector Manufacturing Shortage

Accelerating the production of your viral vector-based therapy requires understanding the strategies and cost-efficiencies available to address the viral vector manufacturing shortage.

Standardization Is Key To Building A Successful Global Business Strategy

Standardized approaches to biomanufacturing can lower costs, improve outcomes, and alter the landscape of the global pharmaceutical market.

Is Not Using A CDMO Slowing Down Your Process Development?

Consider what process development capabilities you have versus what you could possibly gain from working with a CDMO to not only be successful but also improve your chances of getting to market sooner.

Designing Agile Manufacturing With An Integrated Drug Substance/Drug Product Ecosystem

Companies that want to accelerate their biomanufacturing operations and use their resources efficiently need access to technologies and solutions that can safely and efficiently complete their workflow from idea to injection.